Early and proactive engagement with developers is an “absolute imperative” and the UK’s swift approval of a COVID-19 vaccine should be a lesson in how the UK approaches the future development of vaccines and medicines.
That was one of the key messages from June Raine, the long-term interim head of the Medicines and Healthcare products...





